Meiragtx Holdings PLC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NASDAQ
Richard Giroux, CFO & COO of MeiraGTx Holdings plc, sold 56,000 shares of common stock on July 21, 2026 for $12.51 per share.
NASDAQ
MeiraGTx Holdings plc reports that Chief Scientific Officer, Stuart Naylor, sold a significant number of ordinary shares under a pre-arranged trading plan.
NASDAQ
MeiraGTx Holdings plc reports that Chief Medical Officer Robert K. Zeldin was granted 100,000 restricted share units.
NASDAQ
MeiraGTx Holdings plc reports that General Counsel and Secretary Robert J. Wollin acquired 100,000 restricted share units.
NASDAQ
MeiraGTx Holdings plc reports that Chief Scientific Officer, Stuart Naylor, was granted 70,000 restricted share units on June 25, 2026.
NASDAQ
MeiraGTx Holdings plc reports that CFO & COO Richard Giroux was granted 980,000 restricted share units on June 25, 2026, with vesting over four years.
NASDAQ
Alexandria Forbes, President & CEO and Director of MeiraGTx Holdings plc, was granted 980,000 Restricted Share Units.
NASDAQ
Director Debra Yu was granted 60,000 restricted share units (RSUs) by MeiraGTx Holdings plc, vesting in June 2027.
NASDAQ
Director Thomas E. Shenk was granted 69,662 restricted share units in MeiraGTx Holdings plc.
NASDAQ
Director Nicole Seligman was granted 60,000 restricted share units in MeiraGTx Holdings plc as part of annual compensation.
NASDAQ
Director Neil Mendoza was granted 66,641 restricted share units in MeiraGTx Holdings plc, vesting in June 2027.
NASDAQ
Director Ellen Hukkelhoven was granted 60,000 restricted share units in MeiraGTx Holdings plc.
NASDAQ
Director Keith R. Harris was granted 106,441 restricted share units in MeiraGTx Holdings plc.
NASDAQ
Director Keith R. Harris acquired 75,000 ordinary shares of MeiraGTx Holdings plc through the vesting of restricted share units.
NASDAQ
CFO and COO Richard Giroux gifted 7,000 ordinary shares of MeiraGTx Holdings plc, reducing his direct holdings to 964,530 shares.
NASDAQ
MeiraGTx Holdings plc President and CEO Alexandria Forbes sold 62,000 ordinary shares via a pre-arranged 10b5-1 trading plan.
NASDAQ
Chief Development Officer Penny Renee Fleck was granted 100,000 stock options and 100,000 restricted share units by MeiraGTx Holdings plc.
NASDAQ
Chief Medical Officer Robert K. Zeldin filed an amendment to a Form 4 to correct share withholding and rounding errors related to tax obligations.
NASDAQ
Perceptive Advisors reported an acquisition of 555,555 ordinary shares and a repricing of existing warrants to $8.00 per share.
NASDAQ
MeiraGTx CFO and COO Richard Giroux sold 56,000 ordinary shares at an average price of $10.22 per share via a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
Chief Development Officer Stuart Naylor sold 27,661 ordinary shares of MeiraGTx Holdings plc under a pre-arranged trading plan.
NASDAQ
MeiraGTx Holdings plc's President and CEO, Alexandria Forbes, sold 62,000 ordinary shares for a weighted average price of $7.41 per share, executed under a pre-arranged 10b5-1 trading plan.
NASDAQ
MeiraGTx Chief Medical Officer Robert K. Zeldin increased his direct beneficial ownership by 4,548 ordinary shares following the vesting of restricted share units and subsequent tax-related share disposition.
NASDAQ
MeiraGTx General Counsel Robert J. Wollin acquired 11,250 ordinary shares through RSU vesting and subsequently sold 5,949 shares to cover tax obligations.
NASDAQ
MeiraGTx's Chief Development Officer, Stuart Naylor, reported the vesting of 25,000 restricted share units and the subsequent sale of 11,750 shares for tax obligations.
NASDAQ
MeiraGTx Holdings plc's CFO and COO, Richard Giroux, reported the vesting of 60,000 restricted share units and the subsequent disposition of 31,726 shares for tax purposes.
NASDAQ
MeiraGTx Holdings plc's President and CEO, Alexandria Forbes, reported the vesting of 62,500 restricted share units and a subsequent sale of 33,048 shares for tax obligations.
NASDAQ
MeiraGTx Chief Medical Officer Robert K. Zeldin reported the vesting of 35,000 restricted share units and the subsequent sale of 13,951 shares to cover tax obligations.
NASDAQ
MeiraGTx Holdings plc's General Counsel, Robert J. Wollin, reported the vesting of 50,000 restricted share units and the subsequent sale of shares to cover tax obligations.
NASDAQ
MeiraGTx Chief Development Officer Stuart Naylor reported the vesting of 75,000 restricted share units and the subsequent sale of 35,250 shares for tax purposes.